During the sensitization phase, allergens are captured by Langerhans cells and presented to naive T cells, which subsequently leads to the formation of antigen-specific memory cells
Meet our experts Gary Goldenberg , MD, assistant clinical professor of dermatology at the Icahn School of Medicine at Mount Sinai and dermatologist at Mount Sinai Hospital in New York City Cindy Wassef, MD, dermatologist at Premier Health Associates in Randolph, N.J
Real-life Success Stories Case Study 1: John's Journey to a Healthier Life John, a 45-year-old man with a BMI of 35, struggled with obesity for most of his adult life
Live Enhanced's GHK-Cu is a prescription topical product, dispensed following a clinician consultation through the Live Enhanced telehealth platform, with each dose designed to deliver a defined milligram quantity of the active peptide
Expected outcomes based on trial data: Average weight loss of 24.2% at 48 weeks (phase 2) Average weight loss of 28.7% at 68 weeks (phase 3, TRIUMPH-4) 100% of participants achieved 5% or greater weight loss 93% achieved 10% or greater 83% achieved 15% or greater Moderate weight loss protocol (8mg target) For researchers who want significant weight loss but have a lower tolerance for side effects, stopping the escalation at 8mg is a validated approach
N Engl J Med 329(20):14681475 Bartalena L, Kahaly GJ, Baldeschi L et al (2021) The 2021 European Group on Graves orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves orbitopathy